Report cover image

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027

Publisher MarketsandMarkets
Published Jun 11, 2022
Length 287 Pages
SKU # MKMK17255971

Description

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027

The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However,an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the forecasted years.

“The reagents, kits, and consumablesaccounted for the largest market sharein theinfectious disease diagnostics market, byproduct& service, during the forecast period”

The infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. The reagents, kits, and consumables segment accounted for the largest market share in the infectious disease diagnostics market in 2021. Major factors driving the growth of this segment include the increasing number of infectious disease diagnostic tests carried out, the growing need for more reliable, more specific, and faster detection of infectious diseases in the early stages. This is the largest and fastest-growing product segment in the infectious disease diagnostics market. Also, the frequent need for reagents & kits makes it a recurrent cost.

“Mosquito-borne diseasessegment accounted for the highest CAGR”

Based on the disease type, the infectious disease diagnostics market is segmented into COVID-19, HIV, Hospital-acquired infections, hepatitis, Chlamydia trachomatis, Neisseria Gonorrhea, HPV, Tuberculosis, influenza, syphilis, mosquito-borne diseases and other infectious diseases. In 2021, the mosquito-borne diseasessegment accounted for the highest CAGR.

“Diagnostic Laboratoriessegment accounted for the largest market share”

Based on end-users, the infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. The diagnostic laboratories segment accounted for the largest market share in 2021. This can be attributed to the development of complex and highly specialized tests in infectious disease diagnostics and strengthening healthcare infrastructures for efficient disease diagnosis and treatment.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%

By Designation: C-level - 27%, D-level - 18%, and Others - 55%

By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%

Lits of Companies Profiled in the Report:

Abbott Laboratories (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

bioMérieux SA (France)

Thermo Fisher Scientific Inc. (US)

Danaher Corporation (US)

QuidelCorporation(US)

Hologic, Inc. (US)

PerkinElmer Inc. (US)

Bio-Rad Laboratories, Inc. (US)

QIAGEN (Netherlands)

Siemens Healthineers AG (Germany)

Becton, Dickinson and Company (US)

DiaSorin S.p.A (Italy)

Grifols S.A. (Spain)

Sysmex Corporation (Japan)

Seegene Inc. (South Korea)

Ortho Clinical Diagnostics (US)

Genetic Signatures (Australia)

Meridian Bioscience (US)

OraSure Technologies (US)

Trinity Biotech Plc. (Ireland)

Chembio Diagnostic Systems (US)

Co-Diagnostics (US)

ELITechGroup (France)

Epitope Diagnostics (US)

Trivitron Healthcare (India)

Meril Life Sciences Pvt. Ltd. (India)

InBios International (US)

Uniogen Oy (Finland)

Vela Diagnostics (Singapore)

Research Coverage:

This report provides a detailed picture of the global infectious disease diagnostics market. It aims at estimating the size and future growth potential of the market across different segments, such as product& service, test of testing, technology,disease type, end user, and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall infectious disease diagnostics market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

Table of Contents

287 Pages
    • STUDY OBJECTIVES
    • MARKET DEFINITION
    • MARKETS SCOPE
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
    • RESEARCH DATA
    • RESEARCH APPROACH
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE
    • STUDY ASSUMPTIONS
    • LIMITATIONS
    • GROWTH RATE ASSUMPTIONS
    • RISK ASSESSMENT
  • EXECUTIVE SUMMARY
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027
    • INTRODUCTION
    • MARKET DYNAMICS
    • PRICING ANALYSIS
    • PATENT ANALYSIS
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM MARKET MAP
    • PORTER’S FIVE FORCES ANALYSIS
    • PESTLE ANALYSIS
    • REGULATORY LANDSCAPE
    • TRADE ANALYSIS
    • TECHNOLOGY ANALYSIS
    • KEY CONFERENCES & EVENTS IN 2022–2023
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    • KEY STAKEHOLDERS & BUYING CRITERIA
    • CASE STUDY
    • INTRODUCTION
    • REAGENTS, KITS, AND CONSUMABLES
    • INSTRUMENTS
    • SOFTWARE & SERVICES
    • INTRODUCTION
    • LABORATORY TESTING
    • POC TESTING
    • INTRODUCTION
    • PRIMARY NOTES
    • IMMUNODIAGNOSTICS
    • PCR
    • CLINICAL MICROBIOLOGY
    • INAAT
    • DNA SEQUENCING & NGS
    • DNA MICROARRAY
    • OTHER TECHNOLOGIES
    • INTRODUCTION
    • COVID-19
    • HEPATITIS
    • HIV
    • HOSPITAL-ACQUIRED INFECTIONS
    • MOSQUITO-BORNE DISEASES
    • HPV
    • CHLAMYDIA TRACHOMATIS
    • NEISSERIA GONORRHEA
    • TUBERCULOSIS
    • INFLUENZA
    • SYPHILIS
    • OTHER INFECTIOUS DISEASES
    • INTRODUCTION
    • DIAGNOSTIC LABORATORIES
    • HOSPITALS & CLINICS
    • ACADEMIC RESEARCH INSTITUTES
    • OTHER END USERS
    • INTRODUCTION
    • NORTH AMERICA
    • EUROPE
    • ASIA PACIFIC
    • LATIN AMERICA
    • MIDDLE EAST & AFRICA
    • OVERVIEW
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
    • REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • MARKET SHARE ANALYSIS
    • COMPANY EVALUATION QUADRANT
    • COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/ SMES (2021)
    • COMPETITIVE BENCHMARKING
    • COMPETITIVE SCENARIO
    • KEY PLAYERS
    • OTHER PLAYERS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us